These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7052284)

  • 1. Relationship between propranolol kinetics and its electrophysiologic effects.
    Latini R; Riva E; Cremonesi A; Zacá F; Pagliarani P
    Ther Drug Monit; 1980; 2(2):143-4. PubMed ID: 7052284
    [No Abstract]   [Full Text] [Related]  

  • 2. Time course of plasma levels and electrophysiologic effects of propranolol in man.
    Riva E; Latini R; Cremonesi A; Zacà F; Pagliarani P
    J Cardiovasc Pharmacol; 1980; 2(6):707-14. PubMed ID: 6160321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of propranolol.
    Nies AS; Shand DG
    Circulation; 1975 Jul; 52(1):6-15. PubMed ID: 1093761
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.
    Cleaveland CR; Shand DG
    Clin Pharmacol Ther; 1972; 13(2):181-5. PubMed ID: 4401564
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum thromboxane B2 after intravenous administration of talinolol and propranolol in healthy subjects.
    Sziegoleit W; Block HU; Fahr A; Mest HJ
    Pharmazie; 1991 Jan; 46(1):58-9. PubMed ID: 1677468
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of beta blockade with propranolol.
    Hager WD; Pieniaszek HJ; Perrier D; Mayersohn M; Goldberger V
    Clin Pharmacol Ther; 1981 Sep; 30(3):283-90. PubMed ID: 6115730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics and cardiac effects of propranolol in humans.
    Ochs HR; Grube E; Greenblatt DJ; Knüchel M; Bodem G
    Klin Wochenschr; 1982 May; 60(10):521-5. PubMed ID: 7098380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
    Regårdh CG; Johnsson G; Jordö L; Lungborg P; Persson BA; Rönn O
    J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The almost complete hepatic extraction of propranolol during intravenous administration in the dog.
    Shand DG; Evans GH; Nies AS
    Life Sci I; 1971 Dec; 10(24):1417-21. PubMed ID: 5146324
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of the absorption and removal of propranolol in hypertensive patients during therapy.
    Chidsey CA; Morselli P; Bianchetti G; Morganti A; Leonetti G; Zanchetti A
    Circulation; 1975 Aug; 52(2):313-8. PubMed ID: 1149212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
    Coltart DJ; Shand DG
    Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
    Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
    Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.
    Hansson L; Zweifler AJ; Julius S; Hunyor SN
    Acta Med Scand; 1974; 196(1-2):27-34. PubMed ID: 4370849
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of oral propranolol in normal subjects.
    LeWinter MM; Crawford MH; Karliner JS; ORourke RA
    Clin Pharmacol Ther; 1975 Jun; 17(6):709-12. PubMed ID: 1139862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of -adrenergic blocking and non-specific properties of propranolol.
    Coltart DJ
    Br Heart J; 1971 Jul; 33(4):615. PubMed ID: 4397633
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation of propranolol plasma level to beta-blockade during oral therapy.
    Zacest R; Koch-Weser J
    Pharmacology; 1972; 7(3):178-84. PubMed ID: 5054588
    [No Abstract]   [Full Text] [Related]  

  • 18. Lidocaine elimination: effects of metoprolol and of propranolol.
    Conrad KA; Byers JM; Finley PR; Burnham L
    Clin Pharmacol Ther; 1983 Feb; 33(2):133-8. PubMed ID: 6822025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral and intravenous propranolol during exercise.
    Sutton JR; Hughson RL; McDonald R; Powles P; Jones NL; Fitzgerald JD
    Clin Pharmacol Ther; 1977 Jun; 21(6):700-5. PubMed ID: 862308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disposition of propranolol. I. Elimination during oral absorption in man.
    Shand DG; Rangno RE
    Pharmacology; 1972; 7(3):159-68. PubMed ID: 5054586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.